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http://dx.doi.org/10.1016/j.ajic.2014.05.022Background: Although health careeassociated infections are an important cause of morbidity and
mortality worldwide, the epidemiology and etiology of respiratory health careeassociated infections
(rHAIs) have not been documented in Kenya. In 2010, the Ministry of Health, Kenya Medical Research
Institute, and Centers for Disease Control and Prevention initiated surveillance for rHAIs at 3 hospitals.
Methods: At each hospital, we surveyed intensive care units (ICUs), pediatric wards, and medical wards
to identify patients with rHAIs, deﬁned as any hospital-onset (3 days after admission) fever (38C) or
hypothermia (<35C) with concurrent signs or symptoms of acute respiratory infection. Nasopharyngeal
and oropharyngeal specimens were collected from these patients and tested by real-time reverse
transcription polymerase chain reaction for inﬂuenza and 7 other viruses.
Results: From April 2010-September 2012, of the 379 rHAI cases, 60.7% were men and 57.3% were
children <18 years old. The overall incidence of rHAIs was 9.2 per 10,000 patient days, with the highest
incidence in the ICUs. Of all specimens analyzed, 45.7% had at least 1 respiratory virus detected; 92.2% of
all positive viral specimens were identiﬁed in patients <18 years old.
Conclusion: We identiﬁed rHAIs in all ward types under surveillance in Kenyan hospitals. Viruses may
have a substantial role in these infections, particularly among pediatric populations. Further research is
needed to reﬁne case deﬁnitions and understand rHAIs in ICUs.
Published by Elsevier Inc. on behalf of the Association for Professionals in Infection Control and
Epidemiology, Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/3.0/).MPHE, CDC-Kenya, Nairobi,
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licenses/by-nc-nd/3.0/).Health careeassociated infections (HAIs) cause substantial
morbidity and mortality worldwide,1 with prevalence varying from
4%-34% in a variety of patient populations and clinical settings.2-6
Although HAI prevalence, incidence, and burden have been char-
acterized by established surveillance systems in several developed
countries, data on HAIs in developing countries are sparse, espe-
cially in Africa.7,8 Based on a recent review of published studies of
HAI in developing countries, an estimated 15% of hospitalizations
resulted in an HAI, which is much higher than estimated rates (4%-
10%) in developed countries.2,5 In developing countries, resourceInfection Control and Epidemiology, Inc. This is an open access article under the
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measures (eg, hand hygiene, proper disinfection of medical
equipment and surfaces, injection safety, waste management).1,8 In
addition, some factors that are more common in the developing
world (eg, overcrowding of hospital wards, lack of training, fewer
programs on prevention of nosocomial infections) can increase the
likelihood of transmission of respiratory pathogens in health care
settings.9
In Kenya, community-acquired acute respiratory illnesses,
including pneumonia, are common and may account for up to half
of all hospital admissions in medical and pediatric wards.10-15
However, no data are available on respiratory HAIs (rHAIs) in
Kenya. In an effort to understand rHAIs in Kenyan hospitals, in
2009, the Kenya Medical Research Institute (KEMRI), Centers for
Disease Control and Prevention-Kenya (CDC-Kenya), and Kenya
Ministry of Health established a pilot system for tracking rHAIs in
3 hospitals. Laboratory resources and protocols that have been used
for surveillance of community-onset inﬂuenza-like illness (ILI)
were available for testing a subset of rHAI cases with ILI symptoms.
In this study we summarize ﬁndings from this pilot surveil-
lance system. Speciﬁcally, our objectives were to characterize the
epidemiology and etiology of rHAIs stratiﬁed by patient and ward
characteristics and to identify viral pathogens associated with rHAI
in a subset of patients with ILI symptoms.
METHODS
Setting
Three facilities were chosen based on proximity to the KEMRI or
CDC-Kenya Laboratories in Nairobi and Kisumu and to ensure sites
represented were of varying size and resources. These criteria
resulted in the selection of 1 national and 1 district hospital in
Nairobi and a provincial (ie, regional referral) hospital in Kisumu.
Kenyatta National Hospital (KNH), the largest public hospital in the
country, is a university-afﬁliated national referral hospital with
1,800 beds that receives 89,000 admissions per year. Mbagathi
District Hospital (MDH) is a 200-bed hospital with annual admis-
sions of approximately 13,000, which serves the local population
but provides no specialty services or intensive care. KNH and MDH
are both based in Nairobi, the capital of Kenya, which has a popu-
lation of about 3 million people. The provincial hospital, New
Nyanza Provincial General Hospital (NNPGH), is a 300-bed facility
located in western Kenya; it receives approximately 18,000 ad-
missions per year and serves as a regional referral hospital. We
targeted medical wards, pediatric wards (which typically admit
children <13 years old), and intensive care units (ICUs) for the
prospective rHAI surveillance. As a result, there were 394 total
patient beds under surveillance: 212 beds in medical wards
(51 at KNH,101 at NNPGH, 60 at MDH),186 beds in pediatrics wards
(61 at KNH, 80 at NNPGH, 45 at MDH), and 26 beds in general ICUs
(21 at KNH, 5 at NNPGH).
Surveillance protocol and case deﬁnitions
We trained 4 clinicians (1 nurse, 3 clinical ofﬁcers) to be HAI
surveillance ofﬁcers (SOs) and assigned them to the 3 hospitals (1
inMDH,1 in NNPGH, 2 in KNH)where theyworked closely with the
health care personnel and hospital administrators to implement
the surveillance protocol. SOs were instructed to survey each ward
under surveillance at least 2 days per week. They reviewed all
patients’ medical records in the selected wards to identify patients
with new documented axilla fever (38C) or hypothermia
(<35C) with onset at least 3 days after admission to the hospital.
SOs relied on temperatures taken as part of routine clinical care anddocumented in charts. To encourage and enhance consistency of
temperature taking, surveillance wards were provided with Omron
digital thermometers (Omron, Pudong, China) for axilla tempera-
ture taking (thermometer placed in the central position while
adducting the arm close to the chest wall). Because temperature
taking was found to be inconsistent in the prepilot phase, SOs also
took axilla temperatures of all the patients during ward visits to
enhance sensitivity of temperature-based surveillance.
Surveillance began on April 1, 2010, and continued through
September 30, 2012, which composes the 30-month study period
reported here. If new-onset axilla fever or hypothermia were
identiﬁed in a patient who had been afebrile for at least 3 days,
the SOs ﬁlled out a suspected HAI form. The form included in-
formation on basic demographic characteristics, dates of admis-
sion, admitting diagnosis, date of new onset of axilla fever,
clinical symptoms occurring from 1 day before to 3 days after the
onset of fever or hypothermia, and information about routine
laboratory tests ordered, laboratory results obtained, antibiotic
use, and details of patient management. SOs also asked patients
and patient’s family members about clinical symptoms. All pa-
tients with a suspected HAI were followed for their ultimate
outcome, including patient discharge, transfer, or death.
Based on clinical information collected on suspected HAI
cases, respiratory HAIs were characterized by 2 case deﬁnitions.
The ﬁrst was a broad deﬁnition of rHAIs that incorporated a
wide range of respiratory signs and symptoms; the second was a
narrower deﬁnition for hospital-associated ILI. Speciﬁcally, a
case of an rHAI was deﬁned as a patient with new-onset fever or
hypothermia and concurrent (1 day before to 3 days after)
documentation in the medical chart of any of the following in-
dications of respiratory infection: crackles, rhonchi, decreased
breath sounds, crepitus, need for supplemental oxygen in non-
ventilated patients, clinician documentation of upper respira-
tory infection, clinician request for sputum culture, and oxygen
saturation (by pulse oximetry) <90% in ventilated patients or
concurrent patient or family report of cough or sore throat. A
case of hospital-associated ILI was deﬁned as new-onset fever or
hypothermia with concurrent patient or family report of cough
or sore throat. Therefore, the hospital-associated ILI cases rep-
resented a subset of the rHAI cases (Table 1).
Laboratory testing
Because of laboratory resource constraints, SOs were instructed
to collect specimens from patients who met the case deﬁnition for
hospital-associated ILI only. SOs also collected specimens from a
convenience sample of patients who met the rHAI case deﬁnition
but did not meet the ILI case deﬁnition. SOs collected oropharyn-
geal and nasopharyngeal specimens from eligible patients accord-
ing to standard procedures that have been previously described.14
For intubated patients in the ICU in KNH and NNPGH, endotra-
cheal aspirates were collected.
At the KEMRI/CDC-Kenya Laboratory in Nairobi, specimens
were tested by real-time reverse transcription (rRT) polymerase
chain reaction (PCR) for the following pathogens: inﬂuenza
viruses A and B; respiratory syncytial virus (RSV); adenovirus;
parainﬂuenza virus types 1, 2, and 3; and human meta-
pneumovirus. We followed the same testing protocol as previ-
ously described for population-based acute respiratory illness
surveillance in Kenya.15 For rRT-PCR, total RNAwas extracted from
100-mL aliquots of each specimen using QIAamp Viral RNAMini Kit
(Qiagen Inc, Hilden, Germany) according to manufacturer’s in-
structions. One-step rRT-PCR was carried out using the AgPath-ID
One-Step RT-PCR Kit (Applied Biosystems, Carlsbad, CA).
Pathogen-speciﬁc primers were used. Following the reverse
Table 1
Demographics and clinical characteristics for cases of suspected HAI, respiratory
HAI, and hospital-associated ILI, Kenya, 2010-2012
Variable
Suspected
HAI*
(n ¼ 1,255)
Respiratory
HAIy
(n ¼ 379)
Hospital-associated
ILIz
(n ¼ 147)
Sex
Male 694 (55.3) 230 (60.7) 85 (57.8)
Female 561 (44.7) 149 (39.3) 62 (42.2)
Age group, years
<1 206 (16.4) 70 (18.5) 30 (20.4)
1-17 555 (44.2) 147 (38.8) 70 (47.6)
18-49 372 (19.6) 123 (32.5) 40 (27.2)
50-64 80 (6.4) 22 (5.8) 6 (4.1)
65 42 (3.4) 17 (4.5) 1 (0.7)
Hospital
KNH 190 (15.1) 103 (27.2) 58 (39.5)
NNPGH 933 (74.3) 220 (58.1) 43 (29.3)
MDH 132 (10.5) 56 (14.8) 46 (31.3)
Ward type
Pediatrics 690 (55.0) 189 (49.9) 99 (67.4)
Medical 477 (38.0) 116 (30.6) 43 (29.3)
ICU 88 (7.0) 74 (19.5) 5 (3.4)
Length of stay (days)
in the ward, median
(minimum-maximum)
24 (4-657) 25 (4-288) 29 (6-288)
NOTE. Values are n (%) or as otherwise indicated.
HAI, hospital-associated infection; ICU, intensive care unit; ILI, inﬂuenza-like illness;
KNH, Kenyatta National Hospital; MDH, Mbagathi District Hospital; NNPGH, New
Nyanza Provincial General.
*Suspected HAI refers to patients with new documented fever or hypothermia with
onset at least 3 days after admission to the hospital.
yRespiratory HAI refers to patients with suspected HAI and with concurrent
documentation in the medical chart of indication of respiratory infection.
zHospital-associated ILI refers to patients with respiratory HAI with concurrent
onset of cough or sore throat.
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cence was read at the annealing and extension step. Appropriate
negative and positive control specimens were run alongside each
reaction. The results were recorded as crossover threshold (CT)
values. Any pathogen CT value 39.9 was recorded as positive.
Specimens with CT values >40.0 were considered negative, and
those without a CT reading were recorded as negative.
Data analysis
Incidence was calculated by dividing the number of rHAIs and
hospital-associated ILI cases identiﬁed by the number of patient
days under surveillance; the patient-day denominator was deter-
mined from monthly ward-speciﬁc bed occupancy data provided
by each hospital. We used all patient days rather than patient days
at risk (ie, eliminating patient days for those discharged from the
hospital after a stay<3 days) because using overall patient days has
become standard protocol wheremost patient days are contributed
by patients with lengths of stay>3 days.16 Incidence rates for rHAIs
and ILIs were calculated overall and by hospital and ward type.
Stratiﬁed incidence rates were compared using a Poisson regres-
sion (Table 2). Median length of stay was calculated by ward type
and differences compared using Wilcoxon rank-sum tests. Longi-
tudinal trends were plotted quarterly by hospital. Viral pathogen
test results were summarized for patients with hospital-associated
ILI and rHAI.
We analyzed outcomes related to patient discharge status for
those with rHAI. Because patients could have 1 HAI during the
study time period, outcomes were analyzed at the patient level.
Death within 7 days of rHAI onset was used as a proxy for death
attributable to an HAI.17 For patients with multiple rHAIs, the time
from rHAI onset to death was based on the onset of their last rHAI.Characteristics of patients who died within 7 days of onset of rHAI
were compared with patients who died after 7 days and patients
who did not die using c2 tests for independence.
SOs collected all data on paper-based forms until November 30,
2011, at which point they switched to electronic collection of data
on tablets. Data were manually entered into Microsoft Access 2007
(Microsoft Inc, Redmond, WA) prior to December 2011, after which
data were downloaded directly into Microsoft Access from tablets.
Statistical analysis was performed using SAS software version 9.1
(SAS Institute, Cary, NC). The surveillance protocol was approved by
both the Institutional Review Board of CDC-Atlanta and the Ethical
Review Committee of KEMRI.
RESULTS
The surveillance period (April 2010-September 2012) included
a total of 410,182 patient days at the 3 hospitals: 162,394 on
medical wards, 225,354 on pediatric wards, and 22,434 in ICUs.
During this time, SOs identiﬁed 1,255 cases of suspected HAIs;
379 (30.2%, including 18 patients with>1 case) met the deﬁnition
for rHAI, and 147 (11.7%, including 1 patient with 2 cases) cases
met the deﬁnition for hospital-associated ILI. Of the 379 rHAI
cases identiﬁed, 60.7% were men, and 57.3% were <18 years of
age. Of the 147 ILI cases identiﬁed, 57.8% were men, and 68.0%
were <18 years of age; 20.4% were <1 year of age (Table 1). Of the
379 rHAI cases identiﬁed, 49.9% were in pediatrics wards, 30.6%
were in medical wards, and 19.5% were in the ICUs. The median
length of stay in the hospital for rHAI patients was 25 days (range,
4-288); there was no statistically signiﬁcant variation by ward
type.
The overall incidence of rHAI was 9.2 infections per 10,000 pa-
tient days under surveillance (Table 2). The incidence of rHAIs in
the ICUs was 33.0 per 10,000 patient days, which was signiﬁcantly
higher than the incidence in pediatric wards (8.4 per 10,000 patient
days, P < .0001) and medical wards (7.1 per 10,000 patient days,
P < .0001). There was no statistically signiﬁcant difference in the
incidence of rHAI in the pediatrics wards compared with the
medical wards. The incidence of rHAI differed signiﬁcantly by
hospital; it was 18.1 per 10,000 patient days at the NNPGH, 8.4 at
the KNH, and 3.4 at the MDH (P < .0001 for all comparisons).
The overall incidence of hospital-associated ILI was 3.6 per
10,000 patient days (Table 2). By ward type, the incidence was
higher in the pediatrics wards at 4.4 per 10,000 patient days than
the medical wards (2.6, P < .0001) and ICUs (2.2, P ¼ .13). By hos-
pitals, the incidence of hospital-associated ILI was highest at the
KNH at 4.7 per 10,000 patient days. KNH incidence was higher than
the MDH (2.8, P ¼ .007) and NNPGH (3.5, P ¼ .15); however, the
latter comparison did not reach statistical signiﬁcance.
HAIs were detected throughout the year without any clear
seasonal trends. A notable drop in case identiﬁcation occurred in
the last quarter of 2011, and a notable increase in rHAI rates
occurred betweenMarch and November 2011 at the NNPGH (Fig 1).
Specimens were collected and tested for 112 of the 147 sus-
pected hospital-associated ILI cases (76.2%). When we compared
patients from whom specimens were collected with patients from
whom specimens were not collected, there were no signiﬁcant
differences in age, sex, ward type, or hospital. Reasons for not
collecting specimens included refusal by patient or their guardian
or inability to obtain a specimen (eg, because of oxygen mask use,
severe difﬁculty breathing). Among hospital-associated ILI cases, 54
(48% of specimens tested) were positive for at least 1 viral pathogen
(Table 3). The most common viruses identiﬁed among specimens
tested were adenovirus (n ¼ 19, 18.5%), RSV (n ¼ 17, 16.5%), para-
inﬂuenza virus type 3 (n ¼ 16, 15.3%), and inﬂuenza virus A (n ¼ 9,
8.7%). Multiple viruses were isolated for 17 (16.5%) ILI specimens.
Table 3
Viral pathogens detected among patients with respiratory HAI, Kenya, 2010-2012
Variable
Total respiratory
HAI (n ¼ 379)
Respiratory HAI with
hospital-associated
ILI* (n ¼ 147) n (%)
Samples collected for viral testingy 153 (40.4) 112 (76.2)
Sample results availabley 140 (36.9) 103 (70.0)
Any virus* 64 (45.7) 54 (52.4)
Inﬂuenza virus A* 13 (9.3) 9 (8.7)
Inﬂuenza virus B* 10 (7.1) 8 (7.7)
Adenovirus* 22 (15.7) 19 (18.5)
Respiratory syncytial virus* 17 (12.1) 17 (16.5)
Human metapneumovirus* 6 (4.3) 4 (3.9)
Parainﬂuenza virus type 1* 4 (2.9) 3 (2.9)
Parainﬂuenza virus type 2* 2 (1.4) 2 (1.9)
Parainﬂuenza virus type 3* 18 (12.9) 16 (15.3)
Multiple viruses detected 20 (14.2) 17 (16.5)
NOTE. Values are n (%).
HAI, hospital-associated infection; ILI, inﬂuenza-like illness.
*Denominator for the percentage reported is the number of cases that were
swabbed with results available.
yDenominator for the percentage reported is the number of cases meeting the case
deﬁnition.
Table 2
Incidence of respiratory HAI and hospital-associated ILI per 10,000 patient days by ward type and hospital, Kenya, 2010-2012
Ward type
KNH NNPGH MDH Overall
Respiratory
HAI
Hospital-associated
ILI
Respiratory
HAI
Hospital-associated
ILI
Respiratory
HAI
Hospital-associated
ILI
Respiratory
HAI
Hospital-associated
ILI
Medical 4.4 4.2 11.5 1.4 4.0 3.2 7.1 2.6
Pediatrics 6.5 5.6 21.5 6.5 3.0 2.6 8.4 4.4
ICU 21.9 2.5 111.6 0.0 NA* NA 33.0 2.2
Overall 8.4 4.7 13.3 2.6 4.6 3.8 9.2 3.6
HAI, hospital-associated infection; ICU, intensive care unit; ILI, inﬂuenza-like illness; KNH, Kenyatta National Hospital; MDH, Mbagathi District Hospital; NA, not applicable;
NNPGH, New Nyanza Provincial General.
*MDH has no ICU.
Fig 1. Overall respiratory HAI incidence reported per 10,000 patient days by hospital, Kenya, 2010-2012. HAI, health careeassociated infection; KNH, Kenyatta National Hospital;
MDH, Mbagathi District Hospital; NNPGH, New Nyanza Provincial General; PDA, personal digital assistant.
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<18 years old, and 20 (37.0%) were <1 year old.
From the 232 rHAI cases that did not meet the deﬁnition for
hospital-associated ILI, we collected a convenience sample of 37
specimens of which 10 (27%) were positive for at least 1 viral
pathogen. Of these, 6 specimens were identiﬁed from the 69 non-
ILI rHAI cases in the ICUs. The remaining 4 specimens wereidentiﬁed from the 90 non-ILI rHAI cases in the pediatric wards.
Overall, 92.2% of all positive specimens were from patients
<18 years old.
Of the 351 patients with at least 1 case of rHAI, 207 (59.0%) were
discharged from the hospital, 78 (22.2%) died, 36 (10.3%) trans-
ferred, 16 (4.6%) absconded, and 14 (4.0%) were still in the hospital
at the ﬁnal date of data collection. Of the 78 patients who died, 41
(52.6%) of the deaths occurred within 7 days of a new rHAI case
(Table 4). Overall, 10 (58.8%) of the rHAI patients>65 years old died
in the hospital; of those, 6 died within 7 days of having an rHAI. The
proportion of death within 7 days among patients with at least 1
case of rHAI was highest in the ICUs and lowest in pediatric settings
(16.4% vs 9.6%, P ¼ .0001). Fewer patients who had an identiﬁed
virus died within 7 days (4.9%) compared with patients who did not
have any virus identiﬁed (9.9%, P ¼ .007). Among rHAI patients,
having a hospital-associated ILI was not signiﬁcantly associated
with death (Table 4).
DISCUSSION
In this study we report the ﬁrst, to our knowledge, systemati-
cally collected surveillance data in East Africa to estimate the
incidence and viral etiology of rHAI illness. At 3 hospitals in Kenya,
over half of the rHAIs and two thirds of the hospital-associated ILI
cases were identiﬁed in pediatric wards. Incidence of rHAI was
highest in ICUs, whereas incidence of hospital-associated ILI was
highest in pediatric wards. Nearly all of the virus-positive hospital-
associated ILI cases occurred in patients <18 years of age, sug-
gesting that virus transmission among infant and child patients is
Table 4
Characteristics of patients that died within 7 days of respiratory health careeassociated infection and patients who died after 7 days among 337 patients with at least 1
respiratory health careeassociated infection case with outcome information available (ie, not in hospital at time of ﬁnal data collection)
Variable Total (n ¼ 337) Died <7 days (n ¼ 41, 12.2%) Died 7 days (n ¼ 37, 11.0%) Died all (n ¼ 78, 23.1%)
Sex
Male 203 23 (11.3) 19 (9.4) 42 (20.7)
Female 134 18 (13.4) 18 (13.4) 36 (26.9)
Age, years
<1 59 7 (11.9) 4 (6.8) 11 (18.6)
1-17 128 11 (8.6) 9 (7.0) 20 (15.6)
18-49 113 14 (12.4) 17 (15.0) 31 (27.4)
50-64 20 3 (15.0) 3 (15.0) 6 (30.0)
65 17 6 (35.3) 4 (23.5) 10 (58.8)
Ward type
ICU 61 10 (16.4) 14 (23.0) 24 (39.3)
Medical 109 15 (13.8) 15 (13.8) 30 (27.5)
Pediatrics 167 16 (9.6) 8 (4.8) 24 (14.4)
Any inﬂuenza-like illness
Yes 138 13 (9.4) 15 (10.9) 28 (20.3)
No 186 26 (14.0) 21 (11.3) 47 (25.3)
Any virus identiﬁed*,y
Yes 61 3 (4.9) 6 (9.8) 9 (14.8)
No 71 7 (9.9) 18 (25.4) 25 (35.2)
Length of stay, days
Median (minimum-maximum) 11 (5-67) 38 (12-244) NA
NOTE. Values are n (%) or as otherwise indicated.
NA, not applicable.
*Total here is the number of patients who were sampled with results available.
yViruses were much more commonly detected in the pediatric population.
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among rHAI patients in ICUs was lower, the high overall incidence
of rHAI in ICUs suggests that both the speciﬁcity of the rHAI case
deﬁnition and the possibility of bacterial rHAI be further evaluated
in ICU patients.
At the 3 surveillance hospitals in Kenya, the overall rHAI rate
was 9.2 per 10,000 patient days. Although there are few com-
parable studies documenting incidence rates of rHAIs in these
settings, our estimates of an incidence of 8.4 infections per
10,000 patient days in pediatric wards in Kenya are consistent
with a study from Canada that reported an incidence of 2.9-15.0
rHAIs per 10,000 patient days18 in the pediatric population. Our
ﬁndings are also similar to rHAI incidence rates of 7.9 per 10,000
patient days reported in Germany in 2004 for children <3 years
old.19 One primary risk factor for rHAI was the use of respirators,
which were present in the hospitals where both the Canadian
and German studies were conducted; respirators were uncom-
mon in our 3 study sites. Although this difference complicates the
comparison of our ﬁndings with these 2 studies, our ﬁndings still
provide baseline estimates that have some consistency with rHAI
rates observed elsewhere.
There are also some notable differences between our ﬁndings
and other published studies on rHAIs. A study conducted in
Bangladesh in 2011 found the incidence of rHAI to be 5-fold higher
thanwhat we have documented in Kenya.3 This difference could be
caused by differences in data collection strategies; in Bangladesh,
staff gathered data on all rHAIs by visiting wards daily, whereas in
Kenyawe gathered data on all rHAIs by visiting the wards twice per
week. It is also possible that rates of HAI are signiﬁcantly higher in
Bangladesh than in Kenya because of hospital crowding or possibly
because of differences in infection control practices. During the
surveillance period we introduced health education sessions to
health care providers at the 3 study hospitals to improve infection
control practices (eg, hand hygiene). Although the impact of these
health education sessions has not been evaluated formally, it is
possible that the education sessions led to improvements in infec-
tion control in the 3 hospitals, which could also explain why our
reported rHAI rates are lower than those reported in Bangladesh.The percentage of virus-positive samples and the main viruses
we identiﬁed were similar to ﬁndings from recent reports of gen-
eral acute respiratory illness surveillance in Kenya; a recent study of
acute respiratory illness in older children and adults in rural
western Kenya showed similar percent-positive results for in-
patients in regard to any virus identiﬁed (58% compared with 46%
presented here), inﬂuenza virus A (10% compared with 9% pre-
sented here), and RSV (12% compared with 12% presented here).20
Another study reported similar rates of viral pathogens among
infants and children at a rural Kenyan hospital (56% positive for at
least 1 virus), a slightly lower percentage of specimens positive for
inﬂuenza virus A (5.8%), and a higher percentage of RSV-positive
samples (5.8%).21
In the 30 months of HAI surveillance presented in this study,
nearly a quarter of patients with rHAI died while they were in the
hospital, and over half of those deaths were within 7 days of being
diagnosed with an rHAI. Although this study did not measure death
attributable to rHAI, death within 7 days of diagnosis may serve as a
proxy indicator.17 The proportion of rHAI cases with an outcome of
death is higher than reported in similar studies. In a Canadian
study, 9% of febrile rHAI cases died; in a study from Bangladesh, 2%
of rHAI patients died.3,6 These differences suggest the possibility
that our surveillance may have not detected milder cases of HAI; if
so, this may also help to explain the differences in rates of rHAI.
Our data have several limitations that reﬂect the challenges of
sustaining surveillance in low resource settings. Data reported here
may be an underestimation of rHAI for 2 reasons. First, SOs only
visited wards at the most 2 days per week; therefore, they relied on
chart documentation to measure patient temperatures when they
were not at the ward. Wards were understaffed, and thermometers
were scarce; as a result, temperatures weremeasured and recorded
inconsistently in hospital charts. Therefore, rHAI cases were likely
missed. To address some of these issues, we supplied the surveil-
lance wards with digital thermometers and encouraged the ward
nurses to record temperatures. In addition, we likely missed a
number of etiologies of rHAIs because we only tested for some vi-
ruses and did not test for bacteria. Further, we did not follow-up on
any patients following discharge from the wards who may have
L.K. Ndegwa et al. / American Journal of Infection Control 42 (2014) 985-90990developed symptoms from new infections after discharge from the
hospital. Finally, although we chose 3 different kinds of hospitals
(national, provincial, district), our results may not be representative
of all hospitals in Kenya.
To draw on these limitations, lessons learned from the estab-
lishment of this surveillance suggest that future routine HAI sur-
veillance will require more consistent temperature monitoring by
the ward staff and improved documentation of fever on patient
charts. Also, none of the 3 hospitals had any dedicated infection
control nurses. Dedicated infection control staff who have
continual support from the hospital administration and ward staff
can promote HAI awareness and support HAI surveillance efforts.
In conclusion, a new surveillance system for rHAI in 3 hospitals
in Kenya showed that rHAI occurred consistently during a 30-
month period in the pediatric and medical wards and ICUs of 3
hospitals in rates similar to those described in other developing
countries. Most ILI cases tested were positive for at least 1 viral
pathogen. Infection control measures should be strengthened in
Kenyan hospitals, and continued HAI surveillance will be important
to monitor the burden of HAIs and the impact of future infection
control interventions.
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